Question 1

Am I eligible for this trial based on my current health and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits of using lidocaine for my infusion site pain?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

Question 4

How does lidocaine compare to my current pain management options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

Question 5

What would participation in this trial involve in terms of visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any risk of interactions with my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain clinical trial (NCT01433328). Contact the study team or your healthcare provider for specific answers.

What this study is about